EP-2009: Feasibility and early toxicity of HDR alone in pts with recurrent/locally advanced prostate cancer. (April 2016) - Bellia, S.R.; Blanchard, P.; Calmels, L.; Edouard, M.; Maroun, P.; Chaurin, P.; Bossi, A.